Orient Europharma (Taiwan) Probability of Future Stock Price Finishing Over 48.10
| 4120 Stock | TWD 48.10 0.30 0.63% |
Orient |
Orient Europharma Target Price Odds to finish over 48.10
The tendency of Orient Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 48.10 | 90 days | 48.10 | about 73.59 |
Based on a normal probability distribution, the odds of Orient Europharma to move above the current price in 90 days from now is about 73.59 (This Orient Europharma Co probability density function shows the probability of Orient Stock to fall within a particular range of prices over 90 days) .
Assuming the 90 days trading horizon Orient Europharma has a beta of 0.0701. This suggests as returns on the market go up, Orient Europharma average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Orient Europharma Co will be expected to be much smaller as well. Additionally Orient Europharma Co has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Orient Europharma Price Density |
| Price |
Predictive Modules for Orient Europharma
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Orient Europharma. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Orient Europharma Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Orient Europharma is not an exception. The market had few large corrections towards the Orient Europharma's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Orient Europharma Co, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Orient Europharma within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.11 | |
β | Beta against Dow Jones | 0.07 | |
σ | Overall volatility | 1.11 | |
Ir | Information ratio | -0.06 |
Orient Europharma Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Orient Europharma for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Orient Europharma can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Orient Europharma generated a negative expected return over the last 90 days | |
| Orient Europharma has high likelihood to experience some financial distress in the next 2 years | |
| About 65.0% of the company shares are owned by insiders or employees |
Orient Europharma Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Orient Stock often depends not only on the future outlook of the current and potential Orient Europharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Orient Europharma's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 86.7 M |
Orient Europharma Technical Analysis
Orient Europharma's future price can be derived by breaking down and analyzing its technical indicators over time. Orient Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Orient Europharma Co. In general, you should focus on analyzing Orient Stock price patterns and their correlations with different microeconomic environments and drivers.
Orient Europharma Predictive Forecast Models
Orient Europharma's time-series forecasting models is one of many Orient Europharma's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Orient Europharma's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Orient Europharma
Checking the ongoing alerts about Orient Europharma for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Orient Europharma help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Orient Europharma generated a negative expected return over the last 90 days | |
| Orient Europharma has high likelihood to experience some financial distress in the next 2 years | |
| About 65.0% of the company shares are owned by insiders or employees |
Additional Tools for Orient Stock Analysis
When running Orient Europharma's price analysis, check to measure Orient Europharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Orient Europharma is operating at the current time. Most of Orient Europharma's value examination focuses on studying past and present price action to predict the probability of Orient Europharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Orient Europharma's price. Additionally, you may evaluate how the addition of Orient Europharma to your portfolios can decrease your overall portfolio volatility.